Lariago 40mg Injection

Short Description

Lariago 40mg Injection is an antiparasitic medicine used for the prevention and treatment of malaria by killing the malaria-causing parasite.

Dosage Form

Injection

Introduction

Lariago 40mg Injection is administered as an injection by a healthcare professional. Kindly do not self-administer. Take measures to reduce the chance of being bitten by mosquitoes like using insect repellent creams on parts of your body not covered by clothing. Spray mosquito repellent to kill any mosquitoes that may have entered rooms in spite of screening. Wear light-colored and covered clothing when you are outside after sunset. You may experience weakness, vomiting, rash, and itching as side effects of this medicine. It may also cause stomach pain, diarrhea, loss of appetite, and nausea. You may also notice some injection site reactions like pain, swelling, or redness. Please consult your doctor if these side effects persist for a longer duration. Inform your doctor if you have diabetes as it can lower the sugar levels in the blood. If you are diabetic, you should monitor your blood sugar regularly. It may cause blurring of vision. Therefore, regular eye examinations are recommended while on treatment with this medicine. When used long term, your doctor may monitor the amounts of the different types of blood cells in your blood regularly. Inform your doctor if you have unexplained bruising or bleeding, sore throat, fever, or a general feeling of tiredness.

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Side Effects

Weakness Vomiting Rash Itching Stomach pain Diarrhea Loss of appetite Nausea Injection site reactions (pain, swelling, redness)

Alcohol Warning

It is not known whether it is safe to consume alcohol with Lariago 40mg Injection. Please consult your doctor.

Breastfeeding Warning

Lariago 40mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.

Pregnancy Warning

Lariago 40mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Interacting Medicines

Leflunomide Mefloquine Penicillamine Digoxin

Lariago 40mg Injection is an antiparasitic medication that treats malaria. It works by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. This kills the parasite and stops the infection from spreading.

Lariago 40mg Injection is used for the prevention and treatment of malaria. Wear light-colored and covered clothing when you are outside after sunset. Use insect repellent creams or sprays on parts of your body not covered by clothing. Spray to kill any mosquitoes that may have entered rooms despite screening. It may cause a blurring of vision when you first start taking it. Use caution while driving or doing anything that requires concentration. Eye examination before and at 3–6 monthly intervals during use is required if patients are receiving Lariago 40mg Injection at continuous high doses for a longer duration. It may cause low blood sugar levels. Monitor your blood sugar level regularly if you are diabetic. When used long-term, your doctor may monitor the amounts of the different types of blood cells in your blood regularly. Inform your doctor if you have unexplained bruising or bleeding, sore throat, fever, or a general feeling of tiredness.